**Core Concept**
Systemic lupus erythematosus (SLE) is a chronic autoimmune disease characterized by the production of various autoantibodies, including antinuclear antibodies (ANA). These autoantibodies target multiple cellular components, leading to inflammation and tissue damage. The presence of specific autoantibodies can aid in diagnosing SLE.

**Why the Correct Answer is Right**
The antiphospholipid antibody (aPL) is highly specific for systemic lupus erythematosus. aPL is a group of autoantibodies that target phospholipid-binding proteins, including beta-2 glycoprotein I. These antibodies are involved in the pathogenesis of antiphospholipid syndrome (APS), a condition characterized by thrombosis and recurrent fetal loss. In SLE, aPL is often associated with thrombotic events and can be used as a diagnostic criterion.

**Why Each Wrong Option is Incorrect**
* **Option A:** Anti-SSA/Ro and anti-SSB/La antibodies are associated with Sjögren's syndrome, a separate autoimmune disorder characterized by exocrine gland dysfunction.
* **Option B:** Anti-smooth muscle antibodies are found in autoimmune hepatitis, a condition involving liver inflammation.
* **Option C:** Anti-glomerular basement membrane antibodies are associated with Goodpasture's syndrome, a disease characterized by kidney and lung damage.

**Clinical Pearl / High-Yield Fact**
The presence of aPL in SLE patients is associated with an increased risk of thrombotic events, including deep vein thrombosis and pulmonary embolism.

**Correct Answer: A. Antiphospholipid antibody.**